Fem-Dophilus contains two patented and clinically documented probiotic strains, Lactobacillus rhamnosus, GR-1 and Lactobacillus reuteri, RC-14, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech. Over 25 years of research supports the oral use of GR-1 and RC-14 to colonize and promote healthy vaginal and urinary tract health.* A special manufacturing process protects the probiotic strains in Fem-Dophilus from stomach acid and enhances probiotic bacterial survival to the lower intestine.*
Fem-Dophilus does not require refrigeration and can be stored at room temperature. Refrigeration will, however, extend the shelf life. Avoid temperatures above 77???F (25???C).
GR-1/RC-14 and VAGINAL FLORA (also called microbiota)
In one of the randomized clinical trials, 75% of women in the GR-1/RC-14 probiotic group experienced significant improvement in vaginal flora composition, while only 34% of women in the placebo (non-probiotic) group experienced similar improvement.
Serving Size: 1 Vegetable Capsule | Servings Per Container: 30 | ||
| Amount Per Serving | % Daily Value | ||
| Total Probiotic Blend 1 Billion viable cells | |||
| Composed of the following strains: | |||
| Lactobacillus rhamnosus, GR-1?Çá | |||
| Lactobacillus reuteri, RC-14?Çá | |||
Other ingredients: |
*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease.
